BOGDAN A. CZERNIAK, M.D, PHD
Medical Practice at Holcombe Blvd, Houston, TX
License number
Texas J3777
Category
Medical Practice
Type
Anatomic Pathology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about BOGDAN A. CZERNIAK at radaris.comName
Address
Phone
13302 Havershire Ln, Houston, TX 77079
Houston, TX
13302 Havershire Ln, Houston, TX 77079
Professional information
Dr. Bogdan A Czerniak, Houston TX - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
1515 Holcombe Blvd SUITE 85, Houston 77030
(713) 792-6161 (Phone)
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
(877) 632-6789 (Phone)
(713) 792-6161 (Phone)
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
(877) 632-6789 (Phone)
Certifications:
Anatomic Pathology, 1992
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1515 Holcombe Blvd SUITE 85, Houston 77030
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Houston Office
1515 Holcombe Blvd SUITE 10, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
Pomorska Medical Academy
Pomorska Medical Academy
Non-Invasive Detection Of Bladder Cancer By Fluorescence In Situ Hybridization Of Aurora A
US Patent:
2010028, Nov 11, 2010
Filed:
Dec 12, 2008
Appl. No.:
12/811384
Inventors:
H. Barton Grossman - Bellaire TX, US
Bogdan Czerniak - Houston TX, US
Sen Subrata - Sugar Land TX, US
Bogdan Czerniak - Houston TX, US
Sen Subrata - Sugar Land TX, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
We disclose a method of detecting bladder cancer in a patient, comprising isolating bladder cells from the patient's urine; hybridizing the bladder cells with a labelled DNA probe, wherein the probe recognizes at least a portion of the aurora kinase A gene, to yield a sample of bladder cells hybridized with the labeled DNA probe; and counting the number of bladder cells in the sample, the number of copies of the aurora kinase A gene in each bladder cell in the sample, and the number of bladder cells in the sample having at least a first threshold number of copies of the aurora kinase A gene.
Methods Of Detecting, Diagnosing And Treating Cancer And Identifying Neoplastic Progression
US Patent:
2003016, Sep 4, 2003
Filed:
Jun 11, 2002
Appl. No.:
10/167241
Inventors:
Bogdan Czerniak - Houston TX, US
Dennis Johnston - Houston TX, US
Dennis Johnston - Houston TX, US
International Classification:
C12Q001/68
US Classification:
435/006000
Abstract:
Disclosed are methods, compositions and apparatus useful in the detection, monitoring and treatment of the progression of neoplasia and preneoplastic conditions with special emphasis on the chromosomal changes related to the development and progression of urothelial neoplasia. Chromosomal changes, including LOH, at the disclosed loci demonstrate a statistically significant relation to the progression of disease state in urothelial neoplasia.
Detection Of Bladder Cancer
US Patent:
2012023, Sep 13, 2012
Filed:
Mar 12, 2012
Appl. No.:
13/417642
Inventors:
Woonbok Chung - Haverford PA, US
Bogdan A. Czerniak - Houston TX, US
Jean-Pierre Issa - Philadelphia PA, US
Bogdan A. Czerniak - Houston TX, US
Jean-Pierre Issa - Philadelphia PA, US
International Classification:
C12Q 1/68, A61K 33/24, C40B 30/04, A61K 38/21, G01N 21/64, C40B 40/06
US Classification:
424 854, 435 611, 506 16, 506 9, 424649
Abstract:
Provided are methods for detecting bladder cancer in a subject. In some aspects, methylation of one or more of MYO3A, CA10, NKX6-2, SOX11, DBC1, NPTX2, and/or A2BP1 in DNA sediment from a urine sample may be evaluated to detect the presence or absence of a bladder cancer in a human patient.